MedTrace Logo

Curcumin in Kidney Transplant Recipients

NCT03935958 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-05-26

No results posted yet for this study

Summary

The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment who have few treatment options. The possible mechanisms by which curcumin improves vascular function will be evaluated as well as whether curcumin improves cognitive function in these patients.

Conditions

  • Disorder Related to Renal Transplantation

Interventions

DIETARY_SUPPLEMENT

Curcumin

Patients will receive curcumin 2000 mg a day, for 12 months

OTHER

Placebo

Patients will receive placebo capsule identical in appearance and taste to the supplement, for 12 months

Sponsors & Collaborators

  • Verdure Sciences

    collaborator INDUSTRY

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Pierpaolo Di Cocco, MD, PhD · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2023-12-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03935958 on ClinicalTrials.gov